Ongoing projects with Grants obtained (Intramural and extramural) Extra mural  

Dr. Latha Chaturvedula ICMR funded As Principal Investigator: National Registry on COVID-19 infection among pregnant women and their neonates -2020 (Multicentric)   Ongoing
Dr. Latha Chaturvedula ICMR funded Autophagy as a target for therapy in ovarian cancer: a phase II randomised trial with biomarker correlation (Co investigator)   Ongoing
Dr. Latha Chaturvedula ICMR funded Post-operative intraperitoneal chemotherapy after interval cytoreduction in epithelialovarian cancer (POICE): a randomized phase III trial.               (Co-investigator)   Ongoing
Dr. Latha Chaturvedula WHO funded Women’s Health and Domestic violence against women during COVID-19 pandemic in India. Multicentric Trial (Co investigator) 2021 Ongoing
Dr. Latha Chaturvedula ICMR Severity of COVID disease and pregnancy outcome among women with COVID infection with or without COVID vaccination – A multicentric case-control study.   Yet to start. 95 lakh
Dr. Latha Chaturvedula Extramural (DST) Effectiveness of “Pregnancy Tele Yoga Module” on stress, anxiety or depression during COVID-19 Pandemic: a prospective, multi-centre, open-label single-arm exploratory study. 2022 2.4 lakh
Dr. Latha Chaturvedula Extramural DBT Wellcome India Alliance Seroepidemiology, maternal immune status and missed diagnosis of pertussis among young infants in India - a multicentric study. 2022 2.87 crore


Dr. Gowri Dorairajan ICMR funded Micromorphological differences in strong versus weak previous caesarean scar in term pregnant women: a case-control study. 2020-2022 Ongoing. 19.17 lakh
Dr. Gowri Dorairajan National Task Force ICMR extramural ICMR contraceptive registry of PPIUCD and Centchroman users 2018-2021 Ongoing Total 4.8 lakhs per year
Dr Haritha S NACO.  Prevalence of select Sexually Transmitted Infections/Reproductive Tract Infections among sub-populations at High Risk of HIV in India: FSW, MSM, IDU and Migrants.     ₹14, 52,000           
Dr. Chitra T ICMR funded Tranexamic Acid For The Prevention Of Postpartum Haemorrhage After Vaginal Delivery: A Randomized, Double-Blind, Placebo-Controlled Multicentric Trial.(TIP-PPH Trial)     2021 Ongoing; Funding awaited.


1. Dr. Chitra T Guide Assessment of thyroid auto antibodies in euthyroid infertile women with Polycystic Ovarian Syndrome - A cross sectional analytical Study-Ongoing   Intramural Grant Rs.1,04,000
2. Dr. Chitra T Guide The effect of hysterolaparoscopic evaluation on pregnancy rates prior to Intrauterine Insemination and after failed Intrauterine insemination in unexplained infertility – A Randomized controlled trial -Ongoing   Intramural Grant Rs 2,50,000/-
3. Dr. Chitra T Guide Comparison of clinical efficacy & safety profile of Ethinyl estradi-ol(EE) 30 mcg/ Drosperinone (DRSP) 3 mg combination on clinical, hormonal, metabolic parameters and quality of life in over-weight/obese women with normal weight women with polycystic ova-ry syndrome Intramural Grant Rs 2,00,000/-
4. Dr. Chitra T PI Effect of Vasopressin Injection on Ovarian Reserve after Laparoscopic Ovarian Cystectomy for Benign Ovarian Cysts : A Randomized Clinical Trial.-Ongoing Intramural Grant Rs.3,16,000/-
5 Dr. Gowri Dorairajan Guide Study of efficacy and safety of Hygroscopic dilator for pre-induction ripening of cervix in woman with previous one caesarean section at term Ongoing grant of 3 lakhs total
6 Dr S.Murali PI Levonorgestrel intrauterine device verses combined transcervical resection of the endometrium and levonorgestrel intrauterine device in the management of Adenomyosis: A randomized clinical trial. 2.7 Lakh; Ongoing
7. Dr S.Murali Guide Dilapan versus misoprostol for cervical ripening prior to operative resectoscopy. Rs 40,000 ;completed
8 Dr. Latha Chaturvedula   Comparison of 2-year recurrence-free survival among women with locally advanced uterine cervical cancer with and without early clearance of high-risk human papillomavirus after complete response with chemoradiation – A prospective cohort study. 6.25 LAKH Started in 2022

Dr Haritha :

Pregnancy outcome in subclinical hypothyroidism (TSH between 2.5-4 MIU/ml) with and without thyroid peroxidase antibodies..₹1,13,500. 2020- 2021.

Dr Sasirekha R :

  Amount Period of Grant Grant Agency
1 Rs.1,70,000/=  18 months from June 2020 JIPMER (Intramural)
2 Rs.1,16,000/-  18 months from January 2021 JIPMER (Intramural)

   Major Publications (2021-2022)--Indexed Journals 

  1. Sreerama D, Surana M, Moolchandani K, Chaturvedula L, Keepanasseril A, Keepanasseril A, Pillai AA, Nair NS. Percutaneous balloon mitral valvotomy during pregnancy: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2021; 100(4):666-675.
  2. Gowri D, Vandana G, Palanivel C, Subhalakshmi B. Experiences and Felt Needs of Women during Childbirth in a Tertiary Care Centre: a Hospital‑Based Cross‑Sectional Descriptive Study. J Obstet and Gynecol India. 2021;6; XX.
  3. Sireesha MU, Chitra T, Subbaiah M, Nandeesha H. Effect of laparoscopic ovarian cystectomy on ovarian reserve in benign ovarian cysts. J Hum Reprod Sci 2021; 14:56-60.
  4. Bhabani Pegu, Chitra Thyagaraju, Deepthi Nayak,, Murali Subbaiah. Placenta accreta spectrum-a catastrophic situation in obstetrics. Obstet Gynecol Sci. 2021;64(3):239-247.
  5. Subbaiah M, Chaturvedula L, Kubera NS, Raj A. Subsequent pregnancy outcome after uterine compression suture placement for postpartum hemorrhage. Int J Gynaecol Obstet. 2021; 00:1–6.
  6. Subbaiah M, Selvest N, Maurya DK. Comparison of bipolar ball endometrial ablation and transcervical resection of the endometrium in the treatment of heavy menstrual bleeding: A randomized clinical trial. Gynecol Minim Invasive Ther 2021; 10:143-7.
  7. Krishnamurthy A, Durairaj J, Subbaiah M. Evaluation of a symptom-based score in combination with CA125 to predict ovarian malignancy in women with adnexal mass. J Egypt Natl Canc Inst. 2022; 34(1):7.
  8. Harika B, Subbaiah M, Maurya DK. Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia. J Midlife Health. 2021 Jul-Sep; 12(3):206-210.
  9. Parveen S, Rengaraj S, Chaturvedula L. Factors associated with the outcome of TOLAC after one previous caesarean section: a retrospective cohort study. Journal of Obstetrics and Gynaecology. 2022 Apr 3; 42(3):430-6.
  10. Natarajan T, Rengaraj S, Chaturvedula L, Wyawahare M. Predictors of adverse maternal outcome in jaundiced pregnant women identified as having pregnancy-specific liver disease (P-sLD). Journal of Obstetrics and Gynaecology. 2022 Jan 20:1-7


Last Updated :13-Jan-2023